MiR-4638-5p inhibits castration resistance of prostate cancer through repressing Kidins220 expression and PI3K/AKT pathway activity

Yang Wang(Shanghai Jiao Tong University), Ninghan Feng(Jiangnan University), Rong Xiao(Nanjing Medical University), Chuncai Wang(Nanjing Medical University), Xueying Mao(Ministry of Education), Wenping Bao(Nanjing Medical University), Yong‐Jie Lu(Queen Mary University of London), Jian Dong(Fudan University), Zhixiang Shen(Shanghai Jiao Tong University), Yan Wu(First Affiliated Hospital of Jinan University), Xiaojie Lu(Nanjing Medical University), Ning Shao(Institute of Genetics and Developmental Biology), Chun Yang(Union Hospital), Weifei Fan, Liting Wen(Wuxi No.2 People's Hospital), Deshui Yu(Jinzhou Medical University), Caixia Zhu(Wuxi No.2 People's Hospital), Xinyu Xu(Wuxi No.2 People's Hospital)
Oncotarget
June 18, 2016
Cited by 33


Related Papers